Company Team Projects Media Contact
RESTORM COMBIOXIN Neva Phistem Sepstone Scleron


Drug discovery platform aiming at identifying and developing innovative therapies for cancer, by targeting critical pathways in cancer stem cells

Phistem was incorporated in 2009 in Geneva, Switzerland. This new company focuses on critical signaling pathways required for cancer stem cell survival and persistence as well as for tumor growth. It relies on an innovative drug screening platform and a unique technology utilizing relevant human cancer stem cells to efficiently identify and characterize small molecules and other modulators involved in cancer stem cells survival, for use in cancer therapy.